LFST - LifeStance Health Group, Inc.
LifeStance Health Group, Inc. (LFST) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
LifeStance Health Group (LFST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
The consensus price target hints at a 31% upside potential for LifeStance Health (LFST). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
LifeStance Health Group NASDAQ: LFST reported first-quarter 2026 results that management said exceeded expectations and prompted the company to raise full-year guidance across its key metrics. On the company's earnings call, CEO Dave Bourdon highlighted what he described as an “exceptional start to the year,” pointing to revenue growth of more than 21% and adjusted EBITDA topping $50 million.
SCOTTSDALE, Ariz. , May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (Nasdaq: LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 35,000,000 shares of LifeStance's common stock, par value $0.
SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 35,000,000 shares of LifeStance's common stock, par value $0.01 per share (the “Common Stock”) at a public offering price of $8.15 per share, pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”) from certain stockholders of the Company (the “Selling Stockholders”). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive any proceeds from the offering.
This was strongly evidenced by its 21% revenue increase in the first quarter. Its profitability rocketed even higher.
SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”), certain stockholders of the Company (the “Selling Stockholders”) intend to offer 35,000,000 shares of LifeStance's common stock, par value $0.01 per share (the “Common Stock”). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive any proceeds from the offering.
LifeStance Health Group, Inc. (LFST) Q1 2026 Earnings Call Transcript
SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 2026.
SCOTTSDALE, Ariz., April 29, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced that management will present at the following upcoming investor conferences.
Specializing in outpatient mental health services, this hybrid care provider reported a notable insider sale in its latest SEC filing.
APA, MPC, PSX, LFST and GLPEY have been added to the Zacks Rank #1 (Strong Buy) List on April 28th, 2026.
Chemed (NYSE: CHE - Get Free Report) and LifeStance Health Group (NASDAQ: LFST - Get Free Report) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk and profitability. Institutional and Insider Ownership 95.9% of Chemed
LifeStance Health Group, Inc. (NASDAQ: LFST - Get Free Report) has been given an average rating of "Moderate Buy" by the nine brokerages that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation, six have given a buy recommendation and one has assigned a strong buy recommendation to
Analysis of 180,000 Patients Validates Measurement-Informed Care for Anxiety and Depression SCOTTSDALE, Ariz., April 9, 2026 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of outpatient mental health care, published new clinical outcomes data demonstrating that LifeStance patients treated for anxiety and depression broadly experienced clinically significant improvements in their symptoms.
LifeStance Health Group (NASDAQ: LFST - Get Free Report) and Chemed (NYSE: CHE - Get Free Report) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations. Valuation and Earnings This table compares LifeStance
Shares of LifeStance Health Group, Inc. (NASDAQ: LFST - Get Free Report) have earned an average rating of "Moderate Buy" from the nine research firms that are currently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation, six have given a buy recommendation and one has given a strong
LifeStance Health Group, Inc. (LFST) Q4 2025 Earnings Call Transcript